Peri-transplant flow-MRD assessment of cells with leukemic stem cells (LSC) associated phenotype in AML patients undergoing allogeneic stem cell transplantation in CR

Leukemia. 2024 Feb;38(2):386-388. doi: 10.1038/s41375-024-02148-3. Epub 2024 Jan 23.

Authors

Evgeny Klyuchnikov¹, Anita Badbaran², Radwan Massoud², Petra Freiberger², Christine Wolschke², Francis Ayuk², Boris Fehse², Ulrike Bacher³, Nicolaus Kröger²

Affiliations

¹ Department for Stem Cell Transplantation, University Cancer Centre Hamburg-Eppendorf, Hamburg, Germany. [email protected].
² Department for Stem Cell Transplantation, University Cancer Centre Hamburg-Eppendorf, Hamburg, Germany.
³ Department of Hematology and Central Hematology Laboratory, Inselspital, Bern University Hospital, Bern, Switzerland.

PMID: 38263432
DOI: 10.1038/s41375-024-02148-3

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Hematopoietic Stem Cell Transplantation*
Humans
Leukemia, Myeloid, Acute* / genetics
Leukemia, Myeloid, Acute* / therapy
Neoplasm Recurrence, Local
Neoplasm, Residual / genetics
Phenotype
Prognosis